Ghent, Belgium, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan Letter of intent to amend the loan from funds managed by ...
The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
Builds upon existing granted DSR patents in US, Europe, Japan and China Strengthens DSR patent protection based upon extensive clinical and pre-clinical experience Data published in European Journal ...
In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Catumaxomab Is the Only Approved Drug Therapy for Malignant Ascites, a Rare and Debilitating Complication of Advanced-stage CancerLaunch Offers Prolonged Puncture-free Survival and Delayed ...
Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today ...
Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI 48109, USA The end of life for patients with cirrhosis is marked by increased personal and financial costs, largely ...
Episodic angio-oedema with eosinophilia (EAE) or Gleich’s syndrome is a rare condition characterised by recurrent episodes of oedema and eosinophilia, accompanied by urticaria, fever and weight gain.
Static ultrasound guidance is used to select and mark the site of needle insertion immediately before the procedure takes place. Dynamic ultrasound guidance, in contrast, is used to directly visualize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results